Last updated: May 17, 2016
|CMS Measure ID:||CMS109v3|
This measure assesses the number of patients diagnosed with confirmed VTE who received intravenous (IV) UFH therapy dosages AND had their platelet counts monitored using defined parameters such as a nomogram or protocol.
|Initial Patient Population:||
Patients age 18 and older discharged from hospital inpatient acute care with a diagnosis of venous thromboembolism (VTE)and a length of stay less than or equal to 120 days.
Patients with VTE confirmed through a diagnostic test and receiving IV UFH therapy
|Measure Steward:||The Joint Commission|
|Domain:||Effective Clinical Care|
|Next Version:||Venous Thromboembolism Patients Receiving Unfractionated Heparin with Dosages/Platelet Count Monitoring by Protocol or Nomogram|
An increase in rate
The unit of measurement for this measure is an inpatient episode of care. Each distinct hospitalization should be reported, regardless of whether the same patient is admitted for inpatient care more than once during the measurement period. In addition, the eMeasure logic intends to represent events within or surrounding a single occurrence of an inpatient hospitalization.
Treatment adjustment by protocol and/or use of a clinical pathway must be specific to unfractionated heparin therapy. Heparin protocols and clinical pathways may include use of a nomogram.
The construct of Unfractionated Heparin (route: 'Intravenous route') intends to capture continually infused heparin rather than heparin flushes or pushes.